Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study (Q27851763)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study
scientific article

    Statements

    Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study (English)
    Valentina Guarneri
    0 references
    Antonio Frassoldati
    0 references
    Alberto Bottini
    0 references
    Katia Cagossi
    0 references
    Giancarlo Bisagni
    0 references
    Samanta Sarti
    0 references
    Alberto Ravaioli
    0 references
    Luigi Cavanna
    0 references
    Giovanni Giardina
    0 references
    Antonino Musolino
    0 references
    Laura Orlando
    0 references
    Fabrizio Artioli
    0 references
    Corrado Boni
    0 references
    Daniele Giulio Generali
    0 references
    Patrizia Serra
    0 references
    Michela Bagnalasta
    0 references
    Luca Marini
    0 references
    Federico Piacentini
    0 references
    Pierfranco Conte
    0 references
    1 June 2012
    0 references
    30
    0 references
    16
    0 references
    1989-95
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit